The long-term use of marijuana isn’t associated with a decrease in lung function, and may reduce the risk of emphysema, according to a new study published by the journal Chronic Obstructive Pulmonary Diseases.
For the study, researchers examined the relationship between the long-term use of marijuana and lung health in 2,300 patients ages 40 to 80.
“This cross-sectional analysis of participants enrolled into the SPIROMICs cohort was performed to investigate the relationships between marijuana use and pulmonary function and symptoms”, states the study, which notes that “Those enrolled were carefully screened and recruited based on tobacco use history and spirometric function”.
According to researchers; “Neither current nor former marijuana use was associated with increased risk of cough, wheeze, or chronic bronchitis when compared to never marijuana users after adjusting for covariates”. Both current and former marijuana use “was associated with significantly less quantitative emphysema”. In agreement with other published studies, researchers “also did not find that marijuana use was associated with more obstructive lung disease.”
The full text of the study can be found by clicking here. It was conducted by researchers from the following institutions:
National Jewish Health, Denver, Colorado
Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California at Los Angeles
Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine and Cardiovascular Research Institute, University of California San Francisco, School of Medicine, San Francisco
Departments of Radiology, Medicine and Biomedical Engineering, University of Iowa, Iowa City
University of Utah Health Sciences Center, Salt Lake City
Department of Biostatics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora
Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill
Columbia University, Division of General Medicine, New York, New York
In a Marin County hotel room, a group of women are giggling, adjusting each other’s hair and posing for selfies. It’s pretty typical, until you hear the dialogue.
“Fuck Facebook!” one says
“Censorship is bullshit!” barks another.
Yes, this is not just any group of women, and this is not just another gathering of friends. We’d all come together to attend the world premiere of Mary Janes: The Women of Weed at the Mill Valley Film Festival on Oct. 8, but we weren’t as happy as we should’ve been, given that we were hours away from our documentary debut.
As pioneers in an industry being reborn outside of prohibition in a society where women are rarely chosen to lead, we’re well seasoned in the ways of hypocrisy and cannabis. Yet, no matter how far we get forging the path to legitimacy, around every turn is a reminder that we can’t put down our machetes just yet.
On this day, our oppressor was Facebook. The social network had refused to allow ads for Mary Janes, because the film’s about marijuana. Let that sink …
Ross Rebagliati, the world’s first Olympic gold medalist for Men’s Snowboarding and a long-time cannabis activist, believes Olympic events should allow athletes access to cannabis if their countries of origin allow.
Ross Rebagliati had a cannabis business but Kelowna municipality in British Columbia shut it down in late 2017. (Photo via Ross’ Gold Facebook Page)
“Athletes from countries that allow [one of the many psychoactive compounds in marijuana] THC like Canada, America, and other countries in the world like Portugal and Spain, those Olympic athletes should be allowed to use cannabis because that is part of culture they live in,” the 47-year-old Rebagliati told The Puff Puff Post.
As thousands of international athletes ready up for the 2018 winter Olympics in South Korea’s PyeongChang, the trend to legalize marijuana is taking a sweeping effect around the globe.
In 2017, Uruguay became the first country in the world to legalize marijuana, influencing many others to accept cannabis use, at least medicinally. Such is the case in Mexico and Germany.
On Jan. 1, California lent its heavyweight population to be the eighth and the largest U.S. state to legalize recreational marijuana. There is already a dozen of U.S. states that allow the medical use of marijuana.
In Portugal, which already has legal marijuana plantations destined for exports, the Doctors’ Association is calling for the legalization of marijuana-based medicines on Thursday. This is the same day parliament started to debate a draft bill that goes even further, seeking to allow patients to grow pot at home.
Moreover, Rebagliati’s home country – Canada – is expected to become the first developed nation to legalize recreational cannabis this summer.
Rebagliati made international headlines in 1998 not because he won the world’s first ever gold in Men’s Snowboarding for Canada in Nagano, Japan. Rebagliati’s gold medal was almost stripped away from him because the Olympics committee found traces of THC after
Cannabis may help in the treatment of Parkinson’s Disease, according to a new study published in the journalNeurotherapeutics and published online by the U.S. National Institute of Health.
“Previous studies suggest that the endocannabinoid system plays an important role in the neuropathological basis of Parkinson’s disease (PD)”, begin’s the study’s abstract. “This study was designed to detect potential alterations in the cannabinoid receptors CB1 (CB1r) and CB2 (A isoform, CB2Ar), and in monoacylglycerol lipase (MAGL) gene expression in the substantia nigra (SN) and putamen (PUT) of patients with PD.”
According to researchers, the results of the present study “suggest that CB1r, CB2r, and MAGL are closely related to the neuropathological processes of PD.” Therefore, “the pharmacological modulation of these targets [such as through the consumption of cannabis] could represent a new potential therapeutic tool for the management of PD.”
For the full text of the study – conducted by researchers at Miguel Hernández University-CSIC, Instituto de Salud Carlos III and Universidad de Navarra – click here.
Oakland, California is tackling the diversity in cannabis issue head-on. Its Equity Program, passed by the City Council last March, was designed to help the city’s black and Latino residents, granting them 50% of new cannabis business permits for everything from cultivation to manufacturing.
As of Nov. 17, less than four months before adult-use marijuana became legal in California on Jan. 1, 129 of the 255 applications for cannabis-business permits in Oakland had comefrom equity candidates.
The lack of equity up until now is largely due to cities and states not allowing people with criminal records to work in the industry, hence shutting out many people from the racial and ethnic groups that have been disproportionately arrested and incarcerated for possession and sales. In 2011, 90% of all people arrested for marijuana in Oakland were black or Latino.
People from these two groups are nearly four times more likely to be arrested for cannabis possession than whites are, even though use is about the same in each group. The Equity Program was created to deal with this disparity and act as a kind of reparation.
Alcoholics who use cannabis are less likely to have liver disease, according to a new study being published in the journal Liver International and epublished ahead of print by the U.S. National Institute of Health.
“Abusive alcohol use has well-established health risks including causing liver disease (ALD) characterized by alcoholic steatosis (AS), steatohepatitis (AH), fibrosis, cirrhosis (AC) and hepatocellular carcinoma (HCC)”, states the study’s abstract. “Strikingly, a significant number of individuals who abuse alcohol also use Cannabis, which has seen increased legalization globally. While cannabis has demonstrated anti-inflammatory properties, its combined use with alcohol and the development of liver disease remains unclear.” With this in mind, the aim of the study was to “determine the effects of cannabis use on the incidence of liver disease in individuals who abuse alcohol.
For the study, researchers analyzed “the 2014 Healthcare Cost and Utilization Project – Nationwide Inpatient Sample (NIS) discharge records of patients 18years and older, who had a past or current history of abusive alcohol use”. Using the International Classification of Disease, Ninth Edition codes, they “studied the four distinct phases of progressive ALD with respect to three cannabis exposure groups: non-cannabis-users (90.39%), non-dependent-cannabis-users (8.26%) and dependent cannabis users (1.36%).” Researchers “accounted for the complex survey sampling methodology and estimated the adjusted odds ratio (AOR) for developing AS, AH, AC and HCC with respect to cannabis use (SAS 9.4).”
The study “revealed that among alcohol users, individuals who additionally use cannabis (dependent and non-dependent cannabis use) showed significantly lower odds of developing AS, AH, AC and HCC (AOR: 0.55[0.48-0.64], 0.57[0.53-0.61], 0.45[0.43-0.48] & 0.62[0.51-0.76]). Further, dependent users had significantly lower odds than non-dependent users for developing liver disease.”
Researchers conclude by stating that; “Our findings suggest that cannabis use is associated with reduced incidence of liver disease in alcoholics.”
The Hood Incubator in Oakland focuses on increasing the participation of black and brown communities in the cannabis industry.
There have been plenty of stories, blogs and social-media posts about the “whitewashing of the Green Rush.” For years, the Minority Cannabis Business Association and other groups have sounded the alarms about how this new wave of ganjapreneurs is distressingly monochromatic. Is anything actually being done?
Yes, things are being done. Oakland, California, which continues to be far ahead of any other municipality when it comes to cannabis, has approved a program that gives half of new city cannabusiness licenses to people with lower incomes or who live in the neighborhoods that have been hardest hit by the War on Drugs.
Boston Councilwoman Ayanna Pressley is for equity in cannabis.
Massachusetts’ new adult-use pot law has a provision mandating outreach programs to the historically disenfranchised, and Boston City Councilwoman Ayanna Pressley has introduced legislation that would direct 20% of unspent revenues from state and local marijuana taxes toward programs aimed at social justice and creating more opportunities for people of color. Pennsylvania, Ohio and West Virginia have all enacted legislation designed to create more diversity in the cannabis industry. In fact, Pennsylvania requires businesses applying for medical-cannabis licenses to spell out their plan for ensuring a diverse workforce.
Women are taking the lead in cannabis industry in terms of diversity. They fill 36% of the executive positions, according to a 2015 Marijuana Business Daily survey. That’s significantly higher than the 22% national average in the non-weed world.
First passed in 2014, Rohrabacher-Blumenauer (then known as Rohrabacher-Farr) is an amendment to the annual appropriations bill that prohibits the Department of Justice from using federal funds to crack down on medical marijuana programs in the 29 states where it’s legal. In December, President Trump signed a stopgap funding bill that would extend these protections until Jan. 19.
For example, last August, a federal judge in San Francisco cited the amendment in a ruling that two California medical-marijuana growers who’d pleaded guilty to cultivation charges could not be sentenced to prison due to the amendment. And on Oct. 18, federal prosecutors in Washington State admitted that it prohibited them from prosecuting a group of medical growers known as the Kettle Falls Five.
Reps. McClintock and Polis Re-Introduce Their Amendment
Sessions’ decision to revoke federal protections in the eight legal recreational marijuana states has prompted a backlash in Congress. On Jan. 12, a bipartisan group of 69 members sent a letter to Congressional leadership urging them to include the McClintock-Polis amendment in the appropriations bill as well. Introduced by Reps. Tom McClintock (R-Calif.) and Jared Polis (D-Colo.), its language is similar the Rohrabacher-Blumenauer amendment’s, but it would also protect legal state recreational cannabis programs.
In addition, researchers found that “MMLs in inland states lead to a reduction in crime in the nearest border state. Our results are consistent with the theory that decriminalisation of the production and distribution of marijuana leads to a reduction in violent crime in markets that are traditionally controlled by Mexican drug trafficking organisations.”
Specifically, the study concludes that in states bordering Mexico, medical cannabis legalization reduced violent crime by 13% on average.
What are the differences between THC and CBD? Here’s a look.
When you first start smoking weed, you hear the acronyms THC and CBD a lot. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the two main active cannabinoids in the cannabis plant. There are over one hundre other cannbinoids such as THC-V, THC-A, and CBN, but if you’re first starting out you should primarily concern yourself with the first two, at least for now. Cannabinoids are these neat little compounds that interact with the endocannabinoids that naturally occur in your body. Though they are both cannabinoids, there are quite a few differences between THC and CBD. For instance…
CBD is Non Psychoactive
This is one of the biggest differences between THC and CBD. THC is the psychoactive cannabinoid; it’s the one that gets you baked. You know that heavy and relaxing feeling that you get after smoking some OG Kush? That can be attributed to THC. CBD on the other hand, is considered to be non psychoactive. This doesn’t mean that you feel nothing after using a high CBD strain or oil, quite the contrary. You won’t experience a noticeable change in your mood, but your body will feel uplifted and just all around. If you were feeling like you’re coming down with a cold prior to smoking, CBD will make you feel better almost instantly. Hence one of the reasons why CBD strains are more popular among medical cannabis users
CBD has Antipsychotic Properties
Sometimes when you smoke a high THC strain you might feel a little off. You might feel a little paranoid, you might have trouble concentrating, maybe your brain feels a little too slowed down, or maybe you feel dizzy. Regardless the effect, it seems that you got too high. The nice thing about CBD is that it can counteract some of those negative effects, and in some cases erase them entirely. …
There’s a diversity problem in the cannabis industry. Many have already experienced the lack of diversity in other industries, so this story is not new. But why is this so important now? People of color, women and LGBTQ communities have decided about the cannabis industry, “Not again, not this time. We’re going to change this narrative.”
As a black woman of Afro-Latina decent, I’m unapologetic about entering a room and looking for color first. I’m seeking familiar faces, reflections of myself, a commonality and a welcoming nod that says, “I acknowledge you.” For far too long, whether in my professional or personal life, white people have ignored or overlooked me, so the nod lets me know I’m not alone. I also look for women and representation from the LGBTQ community. Yes, I conduct a tally, because I purposely want to know who’s in the room. The same is true when I attend conferences. I want to see who the speakers are and if they reflect our communities.
A Fast Company article in 2015 stated that millennials view diversity as blended experiences, cultures and perspectives. I agree. Our diverse cultures and backgrounds certainly bring a unique richness to the table. That said, it’s our responsibility to hold people and businesses accountable when there’s an imbalance. Being diverse is smart business; just look at TV commercials, and print and digital ads. Society has forced big business into diversity and inclusion—which ultimately benefits consumers and businesses’ global reach.
Many have asked me why I work for Women Grow. The simple answer is I saw where I could make a difference. Together with our CEO, Kristina Garcia (formerly Neoushoff), and our amazing market leaders, we’re committed to seeing change in the cannabis industry. This year, we’ve assembled the most diverse market-leadership and headquarters teams since our inception in 2014. We still have work to do, but I believe we will get there …
Two Massachusetts ganja growers are facing federal felony charges after one of them “was featured in a magazine article noting that he regularly harvests 10 pounds of marijuana,” according to prosecutors.
“Yes, they were featured in High Times,” a spokesperson for the U.S. Attorney’s office in Boston tells Freedom Leaf. “That was a part of how they were spotted.”
The two were first raided in February, shortly after Vallee’s garden was featured in the High Times article, “New England’s Patriot Pot Growers.” The story explained that “Eric regularly harvests 10 pounds of medical cannabis from a space that has just 16 plants under four 1,000-watt HPS lights with a two-and-a-half-week vegetative time.” It also noted that he’d won several Cannabis Cups and worked with Molle.
Cannabis use, even on a regular basis, does not reduce motivation in adolescents, according to a new study published by the journal Substance Use & Misuse and published online by the National Institute of Health.
For the study, researchers examined 79 adolescents ages 14 to 18, who were “classified as recent regular cannabis users (36) or light users (43).” Frequency and amount of substance use “were assessed across participants’ lifetime and during the past 30 days”, and motivation was measured “through the Apathy Evaluation Scale and Motivation and Engagement Scale.” To examine associations between cannabis use (CU) and motivation indices, researchers conducted a series of two-step hierarchical multiple regressions.
After controlling for confounds, “no significant differences were observed between regular and light users on any motivation index”, states the study. Similarly, “no associations between motivation and lifetime or past 30-day CU amount were observed”.
The study concludes by stating; “Our findings do not support a link between reduced motivation and CU among adolescents after controlling for relevant confounds.”
The full study, conducted by researchers at Florida International University, can be found by clicking here.
RFID chips (for Radio Frequency Identification) do as their name implies: They identify the plant, the package of bulk flowers, and the pre-rolled joints, edibles and concentrates made from the flowers. Because the numbers are related to one another, it’s possible to trace a pre-rolled joint back to the plant from which it came.
1. Each marijuana plant being grown by a licensed grower is given a unique identifying number that’s at least 16 digits long, which is recorded onto an RFID chip.
2. Information about the plant, such as strain name, cultivation techniques and yield, is recorded by the growers and input into a database.
3. These databases reside on the “cloud,” which really just means an off-site server. This allows growers, as well as state agencies, to check on plants remotely.
4. The flowers harvested from a plant are given a unique identifying number that’s related to the plant’s unique ID, as are the leaves and the waste matter, such as stems. Those numbers are recorded onto the chips, which are then attached to containers holding the flowers, leaves or waste …
• On being a cannabis consultant for TV shows and movies: “It’s fun and exciting, but representing the industry I love can be stressful. Working on Disjointed required me to be present in the writers’ room to help guide them along, using my 15 years of cannabis-industry experiences. I worked with wardrobe, set designers and the prop department to make sure everything on set felt as authentic as possible. I was on set during rehearsals and tapings to work directly with the cast. It’s so important for the actors to feel comfortable, which is why I had them all spend time inside my real dispensary in West Hollywood.”
• On making the move to recreational sales: “We’re lucky to be located in a very progressive city. West Hollywood gave us a business permit back in 2005, so we’re one of the only four licensed dispensaries in all of Los Angeles. We’re ready for 2018, just in time to celebrate Season 2 of Disjointed on Jan. 12.”
• On women in cannabis: “Sorry boys, the ladies are taking over! Traditionally, men grew and sold cannabis while the women stayed home with the kids. If there was a bust and the man was arrested, the kids still had at least one parent to care for them. Once medical marijuana became widely accepted and legal, more and more women began working as budtenders. Now we’re entrepreneurs, growers and dispensary owners. Not only are women more nurturing, we’re the ones who purchase most of the items for their households. It only makes sense to start marketing to us. We’ve made huge strides in a short amount of time, and I’m so happy to be part of this groundbreaking industry.”
“For decades and decades, we’ve understood that prohibition doesn’t work.”
A study published by Indiana University South Bend found that cannabis use is associated with decreased rates of mortality from obesity, diabetes mellitus, taumatic brain injury, use of alcohol and prescription drugs, driving fatalities, and opioid overdose deaths.
According to the study, there would be “an estimated 23,500 to 47,500 deaths prevented annually if medical marijuana were legal nationwide”, and cannabis prohibition “is revealed as a major cause of premature death in the U.S.”
The statewide legalization of medical marijuana is associated with a reduction in hospitalization from opioids, according to a study conducted at the University of California, and published by both the journal Drug and Alcohol Dependency and the National Institute of Health.
According to a study by BDS Analytics; “Cannabis consumers, it turns out, are among the most well-adjusted and successful of American adults, based on results from BDS Analytics’ landmark cannabis consumer research study, the first of its kind in history. The ongoing study is the most comprehensive and detailed look at cannabis consumers ever conducted.”
Cannabis may provide a treatment option for pulmonary fibrosis, according to a new study published by the journal Oncotarget and published online by the U.S. National Institute of Health.
According to Mayo Clinic, pulmonary fibrosis is “a lung disease that occurs when lung tissue becomes damaged and scarred. This thickened, stiff tissue makes it more difficult for your lungs to work properly.” As pulmonary fibrosis worsens, “you become progressively more short of breath.”
The study’s abstract begins by stating that; “Activation of cannabinoid receptor type 2 [something done naturally through cannabis consumption] has been shown to have anti-fibrosis function in skin and heart. However, whether activating cannabinoid receptor type 2 inhibits pulmonary fibrosis remains elusive.” In this study, researchers “aimed to investigate the role of cannabinoid receptor type 2 in pulmonary fibrosis in vitro and in vivo.”
After conducting their investigation, researchers found the data to indicate that “activating cannabinoid receptor type 2 by a pharmacological method might be a potential strategy for pulmonary fibrosis”.
The full study, conducted by researchers at the Capital Medical University is Bejing, China, can be found by clicking here.
For the modern movement to end cannabis prohibition, Sen. Cory Booker checks off all the boxes when it comes to being an all-star.
The New Jersey Democrat, born in 1969, has lived a remarkable political arc, beginning with outstanding scholarship at Stanford University, attending Oxford University on a Rhodes scholarship and graduating from Yale Law School in 1997. A year later, Booker, not even 30, was elected to Newark’s City Council. In 2006, he became the city’s youngest-ever mayor. Booker received national media attention for the innovative and successful public policies he championed, which put him in position to win a special election for the Senate in 2013 after the death of incumbent Democrat Frank Lautenberg.
From his early days on the City Council, while addressing Newark’s then-rampant crime problems, Booker readily embraced “harm reduction” policies rather than the “arrest and lock them up” mentality long championed by police, prosecutors and prison officials. During his seven years as mayor, he worked with the Drug Policy Alliance to help Newark become a vanguard urban community.
In succeeding Lautenberg, Booker replaced the author of …
The Norwegian Storting (legislature) has approved historic legislation that will decriminalize the possession of all illegal drugs.
According to the Independent, the legislation to decriminalize drug possession was supported by the Conservatives (Hoyre), Liberals (Venstre), the Labor Party (Ap) and the Socialist Left (SV).
“The change will take some time, but that means a changed vision: those who have a substance abuse problem should be treated as ill, and not as criminals with classical sanctions such as fines and imprisonment”, said Sveinung Stensland, deputy chairman of the Storting Health Committee, following the vote.
Nicolas Wilkinson, the SV party’s health spokesman, told VG that parliament’s goal was to “stop punishing people who struggle, but instead give them help and treatment”. He says aim is to transfer responsibility for drug policy from the justice system to the health system.
The move follows a 2006 scheme drug that was intended to replace custodial sentences with treatment programs for drug addicts in the cities of Bergen and Oslo. Last year the scheme was rolled out to all Norwegian courts.
For cannabis enthusiasts—especially in California, where 2018 will mark the legalization of “adult use” sales—who really want to celebrate the holiday season, “yule” get higher than a partridge in a pear tree listening to the following dozen seasonal tokin’ tunes.
1. DENT MAY: “I’LL BE STONED FOR CHRISTMAS”
L.A.-by-way-of Mississippi ukulele auteur Dent May evokes Phil Spector’s Wall of Sound with this poppy piano-driven ode to being home for the holidays. “So I’m trying to get lifted with you now/We broke into my cousin’s stash/We’re having a blast,” he sings “Got an angel on my treetop/And a devil on my mind/Have a smoke and pour a big shot/’Tis the season to be high.” Being the nice young man he is, Dent then apologizes to his mother.
2. ADAM SANDLER: “THE CHANUKAH SONG”
Originally written for Saturday Night Live in 1994, this has become Jewish stoners’ favorite holiday number (to go along with the “Dreidel” song). “So drink your gin and tonic-ah,” Sandler jokes. “And smoke your marijuana-kah.” His riotous roll call of famous members of the tribe includes “All three Stooges!”
Yesterday California’s Bureau of Cannabis Controlissued the first licenses for recreational marijuana businesses, paving the way for legal marijuana sales to begin the beginning of next year.
“This is a great Christmas present,” said California NORML director Dale Gieringer. “Licensing is an inevitable necessity of the modern bureaucratic state. I’m just happy to see the stores open and people be able to walk into a store — any adult including tourists and guests in California — and get cannabis just like they can get alcohol, cigarettes or all sorts of wonderful things in California.”
Altogether 20 licenses were issued to cannabis businesses located throughout the state, including multiple located in San Diego, Lynwood and San Jose. The most – seven in total – are located in Santa Cruz.
Below is a list of the 20 licenses issued yesterday (list provided by GreenState.com):
The United Nations’ World Health Organization (WHO) says that current information doesn’t justify cannabidiol (CBD), a compound found in cannabis, being a controlled substance.
“There is increased interest from Member States in the use of cannabis for medical indications including for palliative care”, states the WHO report released yesterday. “Responding to that interest and increase in use, WHO has in recent years gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components. To that end, the ECDD [Expert Committee on Drug Dependence] did an initial review of a cannabis compound called cannabidiol (CBD).”
The report claims that “Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions. The ECDD therefore “concluded that current information does not justify scheduling of cannabidiol”.
The committee “postponed a fuller review of cannabidiol preparations to May 2018, when the committee will undertake a comprehensive review of cannabis and cannabis related substances.”
Effective today, the Colorado Department of Revenue (CDOR) released statewide historical sales data on marijuana sales from January 2014 to present, and will release monthly reports going forward on the seventh business day of every month.
According to this data – dubbed the Marijuana Sales Report – there has been over $4 billion in marijuana and marijuana products sold since legal recreational sales began in 2014. The data shows that this year (up to the end of October) there has been $1,259,861,988 in marijuana sold, just shy of the $1,307,203,473 sold in 2016. In 2015, there was just shy of $1 billion sold ($995,591,255), and in 2014, the first year of legal sales, there was $683,523,739 sold. For comparison, there has been $2,951,855,447.08 in legal marijuana sold in Washington State, though sales there began in July of 2014, not January like Colorado.
According to the CDOR; “The Marijuana Sales Reports show unaudited monthly sales as self-reported by businesses on State sales returns and do not use Metrc® data (the Marijuana Enforcement Division’s Marijuana Inventory Tracking System). The Marijuana Tax Data reports show tax revenue collected monthly as posted in the State’s accounting system.”
Below is a marijuana sales chart provided by the CDOR:
According to survey data released by the federal government on Monday, the current rate of marijuana use among Colorado and Washington teens is now lower than it was prior to the states legalizing marijuana for adult use.
The rate of past-month marijuana use by individuals ages 12-17 dropped nearly 20% from 11.13% in 2014-2015 to 9.08% in 2015-2016, according to the National Survey on Drug Use and Health (NSDUH) performed by the Substance Abuse and Mental Health Services Administration (SAMHSA). It is now lower than it was in 2011-2012 (10.47%) and 2012-2013 (11.16%). Marijuana became legal for adults 21 and older in December 2012, and legal adult marijuana sales began in January 2014.
The rate of past-month marijuana use among 12-17-year-olds also dropped in Washington (from 9.17% in 2014-2015 to 7.93% in 2015-2016), and it is now lower than it was prior to legalization in 2012 (9.45% in 2011-2012 and 9.81% in 2012-2013).
“Colorado is effectively regulating marijuana for adult use”, says Brian Vicente, partner at Vicente Sederberg LLC, who was one of the lead drafters of Amendment 64 and co-director of the Campaign to Regulate Marijuana Like Alcohol. “Teen use appears to be dropping now that state and local authorities are overseeing the production and sale of marijuana. There are serious penalties for selling to minors, and regulated cannabis businesses are being vigilant in checking IDs. The days of arresting thousands of adults in order to prevent teens from using marijuana are over.”
Vicente continues; “These survey results should come as welcome news to anyone who worried teen marijuana use would increase following legalization. As a proponent of Amendment 64 and a parent of two young children, they certainly came as welcome news to me.”